Final answer:
The FDA publishes Good Manufacturing Practices for the sterile compounding of products. These guidelines help protect the public but may cause delays in new treatments becoming available and incur high testing costs for companies.
Step-by-step explanation:
The organization that publishes the Good Manufacturing Practices (GMP), which offers guidelines for the compounding of sterile products, is the Food and Drug Administration (FDA). The FDA's regulations ensure the safety and efficacy of medicines that pharmacies sell in the United States. While the system benefits the public by protecting them from unsafe drugs, there are also anonymous losers who suffer from these strict regulations, including patients who may wait longer for potentially beneficial treatments due to the lengthy drug approval process and companies that incur high costs during extensive testing periods.